Optibiotix Health

OptiBiotix Health (formerly Ducat Ventures) is a life sciences company developing compounds to tackle obesity, high cholesterol, and diabetes. It develops a range of compounds that modify the human microbiome, to prevent and manage human disease. The company has a pipeline of microbiome modulators that can impact lipid and cholesterol management, energy harvest, and appetite suppression. The product development pipeline is fuelled by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds. These platforms are applicable across a range of other human diseases.